# PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III

> **NCT05934487** · NA · RECRUITING · sponsor: **Endotronix, Inc.** · enrollment: 1750 (estimated)

## Conditions studied

- Heart Failure NYHA Class II
- Heart Failure NYHA Class III
- Heart Failure

## Interventions

- **DEVICE:** Cordella™ Pulmonary Artery Sensor System

## Key facts

- **NCT ID:** NCT05934487
- **Lead sponsor:** Endotronix, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-11-29
- **Primary completion:** 2028-09
- **Final completion:** 2033-09
- **Target enrollment:** 1750 (ESTIMATED)
- **Last updated:** 2026-01-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05934487

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05934487, "PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05934487. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*